Investing in Altimmune Inc (ALT): What You Must Know

In a filing, Altimmune Inc revealed its Director Drutz David acquired Company’s shares for reported $862.0 on Aug 15. In the deal valued at $2.88 per share,300 shares were bought. As a result of this transaction, Drutz David now holds 29,785 shares worth roughly $0.41 million. Then, Eisenstadt Richard I bought 10,000 shares, generating $43,140 […]

ALT Shares Experience Decline in Value

Investors can expect a company’s stock to rise or fall based on the buying and selling of stock by its insiders. Altimmune Inc shares valued at $862 were purchased by Drutz David on Aug 15. At $2.88 per share, Drutz David acquired 300 shares. The insider’s holdings grew to 29,785 shares worth approximately $0.24 million […]

Sharp increase in ALT’s short interest leads to surge in days-to-cover ratio

Investors can speculate about the future of a stock by watching how its insiders buy and sell stocks. Altimmune Inc shares valued at $862 were purchased by Drutz David on Aug 15. At $2.88 per share, Drutz David acquired 300 shares. The insider’s holdings grew to 29,785 shares worth approximately $0.27 million following the completion […]

Analysts review Altimmune Inc’s rating

Altimmune Inc’s recently made public that its Director Drutz David acquired Company’s shares for reported $862.0 on Aug 15. In the deal valued at $2.88 per share,300 shares were bought. As a result of this transaction, Drutz David now holds 29,785 shares worth roughly $0.31 million. Then, Eisenstadt Richard I bought 10,000 shares, generating $43,140 […]

Stocks Of Several Vaccine Makers Dropped In Pre-Holiday Session

Pfizer Inc (PFE) was down -0.45 percent to $37.27 whereas it’s German partner BioNTech SE (BNTX) fell by 3.10 percent to $96.96. On Thursday, the French High Health Authority (HAS) approved the COVID-19 vaccine developed by Pfizer and BioNTech laboratories to be used, the last regulatory move prior to the start of vaccination in France […]